Pfizer: 175/288 (60.8%; 95% interval 55.0–66.2%). Eli Lilly: 128/288 (44.4%; 95% interval 38.8–50.2%).
HEALTH
Pharma & Rx AI Visibility Index 2026
Pharma Companies Index 2.0: Pfizer Leads AI Answers
Published June 28, 2026 · Updated November 7, 2026
AI answers analyzed across ChatGPT, Claude, Gemini and Perplexity
of answers named Pfizer, the most-named (175 of 288)
tracked companies named at least once (of 31)
of Google searches showed an AI Overview (53 of 58)
Version 2. This version replaces the first version of this study, first published August 15, 2026. It uses measured counts, so the two versions are not comparable. Version 2 asks 24 questions three times each on ChatGPT, Claude, Gemini and Perplexity (288 answers) and adds Google AI Overviews. Every rate comes with its count and a 95% interval.
What the data shows
Pfizer
35/288 (12.2%)
18/273 (6.6%)
53/58 (91.4%)
30/53 (56.6%)
33/273 (12.1%)
Appearance rate across 288 four-engine answers. The bar is the 95% confidence interval; overlapping bars cannot be told apart at this sample size.
Which brands AI engines name
| # | Name | Named in | Appearance rate | 95% interval |
|---|---|---|---|---|
| 1 | Pfizer | 175/288 | 60.8% | 55.0–66.2% |
| 2 | Eli Lilly | 128/288 | 44.4% | 38.8–50.2% |
| 3 | Merck | 123/288 | 42.7% | 37.1–48.5% |
| 4 | AstraZeneca | 118/288 | 41.0% | 35.4–46.7% |
| 5 | Sanofi | 117/288 | 40.6% | 35.1–46.4% |
| 6 | Johnson & Johnson | 111/288 | 38.5% | 33.1–44.3% |
| 7 | Novartis | 108/288 | 37.5% | 32.1–43.2% |
| 8 | Bristol Myers Squibb | 104/288 | 36.1% | 30.8–41.8% |
| 9 | Roche | 98/288 | 34.0% | 28.8–39.7% |
| 10 | AbbVie | 89/288 | 30.9% | 25.8–36.5% |
| 11 | Amgen | 83/288 | 28.8% | 23.9–34.3% |
| 12 | GSK | 72/288 | 25.0% | 20.4–30.3% |
| 13 | Novo Nordisk | 69/288 | 24.0% | 19.4–29.2% |
| 14 | Teva | 57/288 | 19.8% | 15.6–24.8% |
| 15 | Viatris | 53/288 | 18.4% | 14.4–23.3% |
The full list
Own-domain citation is the share of 273 grounded answers that cited the tracked name's own domains (subdomains included). Citation share is of all 2,108 citations.
| # | Brand | Named in | Appearance rate | 95% interval | First mention | Own-domain citation | Citation share |
|---|---|---|---|---|---|---|---|
| 1 | Pfizer | 175/288 | 60.8% | 55–66.2% | 4 | 6.2% (17/273) | 1.4% |
| 2 | Eli Lilly | 128/288 | 44.4% | 38.8–50.2% | 4.3 | 2.9% (8/273) | 0.4% |
| 3 | Merck | 123/288 | 42.7% | 37.1–48.5% | 4.3 | 4% (11/273) | 0.5% |
| 4 | AstraZeneca | 118/288 | 41% | 35.4–46.7% | 5.1 | 3.7% (10/273) | 0.5% |
| 5 | Sanofi | 117/288 | 40.6% | 35.1–46.4% | 5.6 | 2.9% (8/273) | 0.4% |
| 6 | Johnson & Johnson | 111/288 | 38.5% | 33.1–44.3% | 4.1 | 1.8% (5/273) | 0.2% |
| 7 | Novartis | 108/288 | 37.5% | 32.1–43.2% | 5.4 | 5.1% (14/273) | 0.8% |
| 8 | Bristol Myers Squibb | 104/288 | 36.1% | 30.8–41.8% | 5.8 | 6.6% (18/273) | 1% |
| 9 | Roche | 98/288 | 34% | 28.8–39.7% | 5.3 | 2.9% (8/273) | 0.4% |
| 10 | AbbVie | 89/288 | 30.9% | 25.8–36.5% | 4.6 | 1.5% (4/273) | 0.2% |
| 11 | Amgen | 83/288 | 28.8% | 23.9–34.3% | 6.4 | 1.5% (4/273) | 0.2% |
| 12 | GSK | 72/288 | 25% | 20.4–30.3% | 6.1 | 2.9% (8/273) | 0.4% |
| 13 | Novo Nordisk | 69/288 | 24% | 19.4–29.2% | 5.3 | 2.6% (7/273) | 0.4% |
| 14 | Teva | 57/288 | 19.8% | 15.6–24.8% | 6.3 | 1.8% (5/273) | 0.2% |
| 15 | Viatris | 53/288 | 18.4% | 14.4–23.3% | 6.3 | 2.9% (8/273) | 0.4% |
| 16 | Regeneron | 49/288 | 17% | 13.1–21.8% | 7.3 | 2.9% (8/273) | 0.5% |
| 17 | Gilead Sciences | 48/288 | 16.7% | 12.8–21.4% | 7.5 | 1.8% (5/273) | 0.2% |
| 18 | Boehringer Ingelheim | 43/288 | 14.9% | 11.3–19.5% | 7.2 | 1.1% (3/273) | 0.1% |
| 19 | Sandoz | 38/288 | 13.2% | 9.8–17.6% | 1.8 | 2.9% (8/273) | 0.4% |
| 20 | Takeda | 38/288 | 13.2% | 9.8–17.6% | 9.8 | 0.4% (1/273) | 0% |
| 21 | Moderna | 33/288 | 11.5% | 8.3–15.7% | 4.7 | 0.7% (2/273) | 0.1% |
| 22 | Biogen | 28/288 | 9.7% | 6.8–13.7% | 6.6 | 1.5% (4/273) | 0.2% |
| 23 | Sun Pharma | 27/288 | 9.4% | 6.5–13.3% | 5.4 | 2.2% (6/273) | 0.3% |
| 24 | Bayer | 21/288 | 7.3% | 4.8–10.9% | 7.1 | 1.1% (3/273) | 0.2% |
| 25 | Vertex Pharmaceuticals | 21/288 | 7.3% | 4.8–10.9% | 7.8 | 0% (0/273) | 0% |
| 26 | BioNTech | 20/288 | 6.9% | 4.5–10.5% | 2.6 | 0% (0/273) | 0% |
| 27 | CSL | 18/288 | 6.3% | 4–9.7% | 5.6 | 1.1% (3/273) | 0.1% |
| 28 | Celltrion | 12/288 | 4.2% | 2.4–7.1% | 4.2 | 0.4% (1/273) | 0% |
The full list (continued)
| # | Brand | Named in | Appearance rate | 95% interval | First mention | Own-domain citation | Citation share |
|---|---|---|---|---|---|---|---|
| 29 | Novavax | 12/288 | 4.2% | 2.4–7.1% | 4.3 | 0% (0/273) | 0% |
| 30 | Samsung Bioepis | 12/288 | 4.2% | 2.4–7.1% | 4.3 | 0.4% (1/273) | 0% |
| 31 | Organon | 10/288 | 3.5% | 1.9–6.3% | 9.1 | 0% (0/273) | 0% |
The top eight, side by side
| # | Name | Appearance rate | Answers and interval | Other measures |
|---|---|---|---|---|
| 1 | Pfizer | 60.8% | 175/288 answers · 95% CI 55–66.2% | first-mention position: 4; owned-domain citation (17/273): 6.2%; citation share: 1.4% |
| 2 | Eli Lilly | 44.4% | 128/288 answers · 95% CI 38.8–50.2% | first-mention position: 4.3; owned-domain citation (8/273): 2.9%; citation share: 0.4% |
| 3 | Merck | 42.7% | 123/288 answers · 95% CI 37.1–48.5% | first-mention position: 4.3; owned-domain citation (11/273): 4%; citation share: 0.5% |
| 4 | AstraZeneca | 41.0% | 118/288 answers · 95% CI 35.4–46.7% | first-mention position: 5.1; owned-domain citation (10/273): 3.7%; citation share: 0.5% |
| 5 | Sanofi | 40.6% | 117/288 answers · 95% CI 35.1–46.4% | first-mention position: 5.6; owned-domain citation (8/273): 2.9%; citation share: 0.4% |
| 6 | Johnson & Johnson | 38.5% | 111/288 answers · 95% CI 33.1–44.3% | first-mention position: 4.1; owned-domain citation (5/273): 1.8%; citation share: 0.2% |
| 7 | Novartis | 37.5% | 108/288 answers · 95% CI 32.1–43.2% | first-mention position: 5.4; owned-domain citation (14/273): 5.1%; citation share: 0.8% |
| 8 | Bristol Myers Squibb | 36.1% | 104/288 answers · 95% CI 30.8–41.8% | first-mention position: 5.8; owned-domain citation (18/273): 6.6%; citation share: 1% |
The four engines named the leading names at similar rates.
ChatGPT
72 asked · 72 returned · 72 grounded
Same questions, different answers
Claude
72 asked · 72 returned · 57 grounded
Gemini
72 asked · 72 returned · 72 grounded
Perplexity
72 asked · 72 returned · 72 grounded
Google AI Overviews were captured through 58 U.S. desktop searches and scored only where an overview appeared, so five-engine figures use 288 + 53 = 341 answers.
The fifth engine
Trigger rate: 53 of 58 searches
Google AI Overviews appeared on 53 of 58 searches (91.4%, CI 81.4–96.3%). The other 5 searches showed no overview. Within the 53 overviews, Pfizer was named in 30 (56.6%), Eli Lilly was named in 22 (41.5%), AstraZeneca was named in 20 (37.7%), Merck was named in 17 (32.1%). en.wikipedia.org was the most-cited source, with 18 citations and an appearance in 18 of 53 overviews.
| Five-engine rank | Name | Five-engine rate | Four-engine rank |
|---|---|---|---|
| 1 | Pfizer | 60.1% | 1 |
| 2 | Eli Lilly | 44.0% | 2 |
| 3 | Merck | 41.1% | 3 |
| 4 | AstraZeneca | 40.5% | 4 |
| 5 | Sanofi | 38.7% | 5 |
| 6 | Johnson & Johnson | 37.0% | 6 |
| 7 | Novartis | 35.5% | 7 |
| 8 | Bristol Myers Squibb | 34.3% | 8 |
| 9 | Roche | 33.4% | 9 |
| 10 | AbbVie | 30.8% | 10 |
Who each question surfaces first
Six questions from the set. Each tile uses that question's own four-engine answers as the denominator.
| Question | Leader | Next | AI Overview |
|---|---|---|---|
| Q01 · 12 answers | Novo Nordisk 100.0% | AI Overview shown on 3 of 3 searches | |
| Q02 · 12 answers | Eli Lilly 100.0% | AI Overview shown on 3 of 3 searches | |
| Q03 · 12 answers | Pfizer 100.0% | Johnson & Johnson 100.0%; AbbVie 100.0% | AI Overview shown on 3 of 3 searches |
| Q04 · 12 answers | Pfizer 100.0% | BioNTech 100.0%; Moderna 100.0% | AI Overview shown on 3 of 3 searches |
| Q05 · 12 answers | AbbVie 100.0% | Amgen 16.7%; Sandoz 16.7% | AI Overview shown on 3 of 3 searches |
| Q06 · 12 answers | Novo Nordisk 100.0% | Eli Lilly 100.0%; AstraZeneca 58.3% | AI Overview shown on 2 of 2 searches |
The four engines produced 2,108 citations in total. sec.gov was cited most often, with 76 citations (3.6%) across 33 answers. Next came fda.gov (53), finance.yahoo.com (43), drugs.com (39), pmc.ncbi.nlm.nih.gov (36), pharmashots.com (35).
Four AI engines · share of 273 grounded answers
Most-cited domains
Google AI Overviews · share of 53 overviews
Citation share by source type
Share of all citations by the type of site cited.
| Source type | Four AI engines (of 2,108 citations) | Google AI Overviews (of 255 citations) |
|---|---|---|
| Other / unclassified | 858 (40.7%) | 100 (39.2%) |
| Research / data providers | 269 (12.8%) | 25 (9.8%) |
| Official / government | 264 (12.5%) | 16 (6.3%) |
| Company / brand sites | 256 (12.1%) | 37 (14.5%) |
| General news / business press | 198 (9.4%) | 0 (0%) |
| Community / social | 71 (3.4%) | 34 (13.3%) |
| Health publishers | 46 (2.2%) | 9 (3.5%) |
| Trade / specialist press | 44 (2.1%) | 11 (4.3%) |
| Reference | 42 (2%) | 18 (7.1%) |
| Directories / rankings | 28 (1.3%) | 0 (0%) |
| Institutions / trade bodies | 28 (1.3%) | 5 (2%) |
| Review / comparison publishers | 4 (0.2%) | 0 (0%) |
How can brands improve their AI visibility?
These steps follow from the measured results above. They describe what the engines cited in this study and are not a guarantee of results.
| Step | What this study measured |
|---|---|
| Put your facts on your own domain. | Bristol Myers Squibb's own domains were cited in 6.6% of grounded answers, Pfizer's in 6.2% and Novartis' in 5.1%. |
| Keep your facts accurate on the sites engines cite. | The most-cited sites other than the tracked names' own were sec.gov (in 12.1% of grounded answers), finance.yahoo.com (11.7%), fda.gov (10.6%), drugs.com (10.6%) and pmc.ncbi.nlm.nih.gov (9.5%). Research and data providers supplied 12.8% of citations and official and government 12.5%. |
| Check each engine separately. | Claude named Sanofi in 50.0% of answers against 31.9% on ChatGPT. Claude named Novo Nordisk in 30.6% of answers against 16.7% on ChatGPT. |
| Watch names outside the tracked list. | Zepbound (15 answers), GSK plc (15 answers), Lupin Limited (15 answers), Aurobindo Pharma Limited (14 answers), Cipla Limited (14 answers) were named often but were not tracked. |
| Re-run the same questions every month. | Compare counts and intervals, not ranks. The 24 questions are in the appendix. |
What AI answers
Which watch brands lead these AI answers?
Pfizer leads this measured set. Pfizer: 175/288 (60.8%; 95% interval 55.0–66.2%). Eli Lilly: 128/288 (44.4%; 95% interval 38.8–50.2%).
Which company is named first most often?
Pfizer was the first company named in 35 of 288 answers, with an average first position of 4.
How often do Google AI Overviews appear for these questions?
An overview appeared on 53 of 58 searches (91.4%, CI 81.4–96.3%). Within those 53 overviews, Pfizer was named most often, in 30 (56.6%).
Which sources do the engines cite?
Across 2,108 four-engine citations, sec.gov was cited most (76 citations, in 33 of 273 grounded answers), followed by fda.gov (53 citations).
Do the four engines agree?
Largely. No tracked name differed by more than 12 points between engines.
How this study was measured
24 questions × 3 runs each × 4 AI engines = 288 answers + 58 Google searches · 53 AI Overviews
24 questions asked three times on each of ChatGPT, Claude, Gemini and Perplexity, measured November 2 to 3, 2026. United States, English; Google retrieval uses desktop results. Models: gpt-5-mini, claude-sonnet-5-5, gemini-3.6-flash only, sonar-pro. Google AI Overviews come from DataForSEO, not inferred chat answers. Appearance counts returned text, including ungrounded answers; citation rates use grounded answers. Longer overlapping names suppress shorter ones; First mention is the earliest eligible name order. Own-domain rates include declared domains and subdomains; shared parent scopes may count for multiple names and cannot be summed as unique citations.
| Engine | Model IDs called | Asked | Returned | Grounded |
|---|---|---|---|---|
| ChatGPT | gpt-5-mini | 72 | 72 | 72 |
| Claude | claude-sonnet-5-5 | 72 | 72 | 57 |
| Gemini | gemini-3.6-flash | 72 | 72 | 72 |
| Perplexity | sonar-pro | 72 | 72 | 72 |
| Google AI Overviews | DataForSEO Google SERP (live, advanced) | 58 | 53 shown | 53 |
Own-domain citations count a domain plus all its subdomains, with the same rule in every table.
Definitions
- Appearance rate: answers naming the tracked name ÷ answers returned, with Wilson 95% intervals.
- First mention: average order in which the tracked name first appears (1 = first).
- Own-domain citation: grounded answers citing the tracked name's domains ÷ grounded answers.
- Citation share: citations to the tracked name's domains ÷ all citations.
Limits
- Only 31 tracked companies are ranked; results are not an exhaustive market ranking.
- Only the tracked companies were scored. Untracked names that appeared often were not scored, including Zepbound (15 answers), GSK plc (15 answers), Lupin Limited (15 answers), Aurobindo Pharma Limited (14 answers), Cipla Limited (14 answers).
- 346 of 360 planned results were returned. 14 AI Overview lookups were excluded after at most three total attempts.
- 58 successful Google searches: 53 overviews shown; 5 without an overview. Failures are excluded, not scored as zero.
- 15 chat answers had no search sources and are left out of the citation figures.
- Measured across two days, November 2 to 3, 2026.
- No Core question names a tracked name.
- Names with no tracked own site are shown with a dash. Source types use Company / brand sites only for verified official organisations; other unresolved sites are Other / unclassified.
- Wilson 95% intervals are descriptive; overlapping leading intervals do not establish a sole leader. Measurements do not endorse medical, legal, financial or product claims.
- This report counts company names in AI answers only. It makes no safety, efficacy or prescribing claim, and being named is not an endorsement. SEC filings are reported as cited sources separately from the company ranking.
- Google Shopping links and Google redirect URLs are not counted as cited sources; original URLs remain in the evidence.
- Answers were collected through each engine's API using the model IDs listed in the methodology. The consumer ChatGPT, Claude, Gemini and Perplexity apps can answer differently.
Appendix: The 24 questions
Questions marked "Core question" are the original study questions, asked word for word. The others are added neutral questions.
| # | Question | Group | Source |
|---|---|---|---|
| 01 | Which company makes Ozempic? | Pharma Companies Index 2.0 | Core question |
| 02 | Which company makes Mounjaro and Zepbound? | Pharma Companies Index 2.0 | Core question |
| 03 | What are the largest pharmaceutical companies in the world? | Pharma Companies Index 2.0 | Core question |
| 04 | Who makes the COVID-19 vaccine? | Pharma Companies Index 2.0 | Core question |
| 05 | What company makes Humira? | Pharma Companies Index 2.0 | Core question |
| 06 | Which companies make GLP-1 weight-loss drugs? | Pharma Companies Index 2.0 | Core question |
| 07 | Which pharmaceutical companies lead in cancer drugs? | Pharma Companies Index 2.0 | Core question |
| 08 | Which companies make the most widely used vaccines? | Pharma Companies Index 2.0 | Core question |
| 09 | Which drugmakers make generic medicines? | Pharma Companies Index 2.0 | Core question |
| 10 | Which companies make biosimilars? | Pharma Companies Index 2.0 | Core question |
| 11 | Which pharmaceutical companies are leading in obesity treatments? | Pharma Companies Index 2.0 | Core question |
| 12 | Who makes Keytruda? | Pharma Companies Index 2.0 | Core question |
| 13 | What are the largest pharmaceutical companies in the US? | Pharma Companies Index 2.0 | Added question |
| 14 | Which large pharmaceutical companies publish research spending in their annual filings? | Pharma Companies Index 2.0 | Added question |
| 15 | Which companies make HIV medicines? | Pharma Companies Index 2.0 | Added question |
| 16 | Which companies make flu vaccines? | Pharma Companies Index 2.0 | Added question |
| 17 | Which companies make immunology drugs? | Pharma Companies Index 2.0 | Added question |
| 18 | Which company makes Dupixent? | Pharma Companies Index 2.0 | Added question |
| 19 | Which company makes Eliquis? | Pharma Companies Index 2.0 | Added question |
| 20 | Which pharmaceutical companies make cardiovascular drugs? | Pharma Companies Index 2.0 | Added question |
| 21 | Which companies focus on rare disease treatments? | Pharma Companies Index 2.0 | Added question |
| 22 | Which pharmaceutical companies work on Alzheimer's treatments? | Pharma Companies Index 2.0 | Added question |
| 23 | Which drugmakers disclose cancer-drug patent expiry dates in company filings? | Pharma Companies Index 2.0 | Added question |
| 24 | Which generic drugmakers publish manufacturing quality information? | Pharma Companies Index 2.0 | Added question |
About 5W
5W is an independent PR, creative and AI Visibility agency founded in 2003, and we get you in the chatbox. All of our work is done in house, including media relations, site building and content. Learn more about our GEO practice or write to info@5wpr.com.
Full report
Read the PDF
Get in touch
Let's build your next chapter.
Tell us what you're working on. A senior strategist will respond within one business day.
- info@5wpr.com
- Phone
- 212.999.5585
- Offices
- Miami · HQ100 SE 2nd Street, Floor 38
Miami, FL 33131Tampa110 South 12th Street
Tampa, FL 33602New York469 7th Avenue, Floor 8
New York, NY 10018



